BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8688539)

  • 1. [Effect of nimodipine on the intracellular calcium level and platelet aggregation in ischemic stroke patients].
    Prianikova NA; Dukhanin AS; Stakhovskaia LV; Chekneva NS
    Biull Eksp Biol Med; 1996 Mar; 121(3):317-20. PubMed ID: 8688539
    [No Abstract]   [Full Text] [Related]  

  • 2. From pharmacological promises to controlled clinical trials to meta-analysis and back: the case of nimodipine in cerebrovascular disorders.
    Di Mascio R; Marchioli R; Tognoni G
    Clin Trials Metaanal; 1994 Apr; 29(1):57-79. PubMed ID: 10150186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet function and antiaggregant therapy in ischemic stroke.
    Pettigrew LC; Wu KK
    Semin Neurol; 1986 Sep; 6(3):293-8. PubMed ID: 3332433
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mechanism of action of adenosine on intracellular calcium and platelet aggregation].
    Feoktistov IA; Pol S; Khollister AS; Robertson D; Biadzhoni I
    Kardiologiia; 1991 Nov; 31(11):76-9. PubMed ID: 1666665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of nimodipine on platelet aggregation and thrombosis.
    Ren YJ; Lü AG; Zhang GQ; Jia DH
    Zhongguo Yao Li Xue Bao; 1998 Mar; 19(2):158-60. PubMed ID: 10374642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of a micellar preparation of polyunsaturated phosphatidylcholine on platelet aggregation in vitro].
    Vlasova II; Torkhovskaia TI; Fortinskaia ES; Khalilov EM; Azizova OA
    Biull Eksp Biol Med; 1996 Feb; 121(2):199-203. PubMed ID: 9026131
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet aggregation and adenosine diphosphate/adenosine triphosphate receptors: a historical perspective.
    Packham MA; Mustard JF
    Semin Thromb Hemost; 2005 Apr; 31(2):129-38. PubMed ID: 15852216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of platelet aggregation during antiplatelet therapy in ischemic stroke.
    Pongrácz E
    Clin Hemorheol Microcirc; 2004; 30(3-4):237-42. PubMed ID: 15258349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of ADP-induced aggregation by 5-HT in rabbit platelets.
    Li BY; Bai Y; Li WH
    Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):58-62. PubMed ID: 10375761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of "xanthinol niacinate" on platelet aggregation.
    Balkuv S; Akman N; Ulutin ON
    New Istanbul Contrib Clin Sci; 1967; 9(2):49-51. PubMed ID: 16300148
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of nisoldipine on red cell deformability and platelet aggregation in stroke patients.
    Kuzuya F; Hayakawa M
    Arzneimittelforschung; 1994 Nov; 44(11):1214-6. PubMed ID: 7848334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongation.
    Cook JJ; Sitko GR; Holahan MA; Stranieri MT; Glass JD; Askew BC; McIntyre CJ; Claremon DA; Baldwin JJ; Hartman GD; Gould RJ; Lynch JJ
    J Pharmacol Exp Ther; 1997 May; 281(2):677-89. PubMed ID: 9152373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo effect of chloroquine on platelet aggregation in anesthetized rats.
    Osim E; Mudzudzu B; Musabayane CT; Coutts A
    Haematologica; 1999 Jan; 84(1):92-3. PubMed ID: 10232936
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
    McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
    Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of carnosine and its derivatives on ADP-induced human platelet aggregation].
    Nikitenko NIu; Shavratskiĭ VKh; Boldyrev AA; Suslina ZA; Ionova VG
    Vopr Med Khim; 1995; 41(1):41-3. PubMed ID: 7771091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADP-mimicking platelet aggregation caused by rugosin E, an ellagitannin isolated from Rosa rugosa Thunb.
    Teng CM; Kang YF; Chang YL; Ko FN; Yang SC; Hsu FL
    Thromb Haemost; 1997 Mar; 77(3):555-61. PubMed ID: 9066010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet response to clopidogrel is attenuated in diabetic patients undergoing coronary stent implantation.
    Geisler T; Anders N; Paterok M; Langer H; Stellos K; Lindemann S; Herdeg C; May AE; Gawaz M
    Diabetes Care; 2007 Feb; 30(2):372-4. PubMed ID: 17259513
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes in platelet response to adenosine 5'-diphosphate caused by verapamil.
    Walkowiak B; Koziołkiewicz W; Michalec L; Pawłowska Z; Krzesłowska J; Cierniewski CS
    Pol J Pharmacol; 1996; 48(3):303-5. PubMed ID: 9112667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comment on "hyperresponsiveness of platelets in ischemic stroke" by Fateh-Moghadam et al.
    Smout J; Cleanthis M; Stansby G
    Thromb Haemost; 2008 Jan; 99(1):239. PubMed ID: 18217162
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of N-(3-hydroxy-1,3,5,(10)estratrien-17 beta-yl)-3-hydroxypropyl-amine (prolame) and estradiol-17 beta on platelet aggregation.
    Baños G; De la Peña A; Izaguirre RR; Mandoki JJ; Mendoza-Patiño N; Rubio-Póo C; Fernández JM
    Proc West Pharmacol Soc; 1991; 34():79-83. PubMed ID: 1788347
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.